European Tourists to the UK Could Drop by a Third Following Brexit
A vote to leave the European Union this month could cost the UK’s tourism industry as much as £4.1 billion a year in international tourist spending alone. According to new research* published today by global travel deals publisher Travelzoo (NASDAQ: TZOO), a third of travellers from Germany, Italy and Spain – and a quarter from France – say they would be less inclined to travel to the UK in the event of a Leave vote. Four in 10 respondents from EU countries also worry that Brexit could make UK holidays more expensive.
Sentiment among the four largest European Union nations (France, Germany, Italy and Spain) is that the UK should stay in the EU, with just under 70% in the Remain camp. In spite of this, respondents from some nations – notably France – believe that leaving the EU could make the UK a safer destination for holidays.
Although almost 75% of the UK’s international visitors come from within the EU, even respondents from further afield (10% of those from Canada and 12% from the US) stated they would be less likely to come to a post-Brexit UK.
Holidays for British tourists in Europe, meanwhile, could become more expensive if the sentiment expressed by some of our neighbours in France and Spain becomes more widespread: 40 per cent of respondents from these countries feel it would be fair to impose higher fees, such as a hiked city tax, on British visitors, if the UK votes Leave on June 23.
UK travellers have their own concerns regarding the impact Brexit could have on the cost of their holiday. Over a quarter (28%) are concerned that withdrawal from the EU could lead to more expensive holidays for them, while 56% are worried that Brexit would reduce the ease and flexibility with which British nationals can currently travel inside the EU.
Other UK tourist concerns include:
- The price of holiday insurance – 25% are worried that the price of holiday insurance would go up, and 20% worry that their holiday protection cover would be impacted if they were no longer entitled to a European Health Insurance Card
- The cost of mobile roaming – 24% are concerned that roaming charges will increase if Britain is no longer governed by European Union roaming regulations
- The impact for UK beaches – 22% worry that UK beaches could become more polluted without strict regulations enforced by the EU
Joel Brandon-Bravo, UK Managing Director of Travelzoo, said: “Our neighbours in Europe clearly don’t want the UK to leave the EU, and the impact of this sentiment could translate into a significant drop in bookings to the UK from the largest European countries. When combined with a potential loss of more than 10 per cent of visitors from North America, as indicated in our research, it’s clear that Brexit could be very bad news for the UK’s domestic tourism industry. Similarly, UK consumers looking to travel abroad also have concerns about Brexit impacting the outbound tourism industry.”
John Fletcher, Pro Vice Chancellor at Bournemouth University (one of the top global academic institutions specialising in travel and tourism), concluded: “Although the impact of Brexit on tourism is a difficult one to predict, given that France, Germany, Italy and Spain make up four of the UK’s top seven tourist-supplying countries – accounting for more than 11 million international visitors annually – it’s likely that the net result of Brexit will be significantly negative for the UK economy. While the figures above reflect only the direct tourism-related economic impacts of voting to leave the EU, if tourist spending from overseas visitors did indeed fall by £4.1 billion per year, this is likely to reduce HMRC revenue by more than £1.1 billion and reduce support for around 63,000 jobs in the UK.
“Even though a UK exit would take some time to complete, especially as renegotiating our revised status with Europe could take five to seven years from start to completion, there will be immediate effects created by this uncertainty.”
Other key findings:
- The Travelzoo survey of 3,050 British people indicates 46% believe the UK should stay in the EU, while 40% believe it’s time to leave – 14% remain unsure
- Around a third of Italian (33%), Spanish (33%) and German (30%) travellers, and a quarter of those from France (24%), would be less inclined to travel to the UK in the event of a Leave vote
- 10% of British people admit they have taken the impact of Brexit into consideration when planning their holiday
- 12% of Americans and 10% of Canadians say if the UK leaves the EU they would be less likely to travel here. American visitors currently spend more than £3 billion a year in the UK
- Interestingly for those in favour of an independent UK, 61% said they’d be willing to pay more for their holidays
*About the research
Travelzoo’s survey was conducted using an online questionnaire in the five largest European Union member states by population, and the US and Canada. The questionnaire was completed by 4,950 Travelzoo members across France, Spain, Germany, the US and Canada. For the UK and Italy Travelzoo commissioned independent research with Atomik Research surveying 2,004 consumers in the UK and 1,003 consumers in Italy.
Tourist spending figures calculated by Bournemouth University using data from Travelzoo’s research and figures from VisitBritain’s Inbound Tourism Reports: https://www.visitbritain.org/inbound-tourism-performance
Travelzoo is a global media commerce company. With more than 28 million members in Asia Pacific, Europe and North America, and 25 offices worldwide, Travelzoo® publishes offers from more than 2,000 travel, entertainment and local companies. Travelzoo’s deal experts review offers to find the best deals and confirm their true value.
Certain statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements may include, but are not limited to, statements about our plans, objectives, expectations, prospects and intentions, markets in which we participate and other statements contained in this press release that are not historical facts. When used in this press release, the words “expect”, “predict”, “project”, “anticipate”, “believe”, “estimate”, “intend”, “plan”, “seek” and similar expressions are generally intended to identify forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including changes in our plans, objectives, expectations, prospects and intentions and other factors discussed in our filings with the SEC. We cannot guarantee any future levels of activity, performance or achievements. Travelzoo undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release. Travelzoo and Top 20 are registered trademarks of Travelzoo. All other names are trademarks and/or registered trademarks of their respective owners.
Laura Higgins, +44-(0)-207-420-0498
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38 | Pressemelding
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00 | Pressemelding
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 09:00 | Pressemelding
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom